- Home
- SSD vs BBIO Comparison
SSD vs BBIO Comparison
Compare SSD & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSD
- BBIO
- Stock Information
- Founded
- SSD 1956
- BBIO 2015
- Country
- SSD United States
- BBIO United States
- Employees
- SSD N/A
- BBIO N/A
- Industry
- SSD Industrial Machinery/Components
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SSD Consumer Discretionary
- BBIO Health Care
- Exchange
- SSD Nasdaq
- BBIO Nasdaq
- Market Cap
- SSD 6.2B
- BBIO 6.7B
- IPO Year
- SSD 1994
- BBIO 2019
- Fundamental
- Price
- SSD $157.45
- BBIO $34.17
- Analyst Decision
- SSD Buy
- BBIO Strong Buy
- Analyst Count
- SSD 2
- BBIO 12
- Target Price
- SSD $188.50
- BBIO $57.09
- AVG Volume (30 Days)
- SSD 210.0K
- BBIO 3.1M
- Earning Date
- SSD 04-28-2025
- BBIO 04-29-2025
- Dividend Yield
- SSD 0.71%
- BBIO N/A
- EPS Growth
- SSD N/A
- BBIO N/A
- EPS
- SSD 7.68
- BBIO N/A
- Revenue
- SSD $2,240,455,000.00
- BBIO $127,415,000.00
- Revenue This Year
- SSD $3.80
- BBIO $13.67
- Revenue Next Year
- SSD $5.70
- BBIO $118.02
- P/E Ratio
- SSD $20.50
- BBIO N/A
- Revenue Growth
- SSD 1.38
- BBIO N/A
- 52 Week Low
- SSD $137.35
- BBIO $21.62
- 52 Week High
- SSD $197.82
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- SSD 57.02
- BBIO 44.19
- Support Level
- SSD $151.90
- BBIO $33.92
- Resistance Level
- SSD $158.20
- BBIO $39.16
- Average True Range (ATR)
- SSD 4.01
- BBIO 1.50
- MACD
- SSD 0.91
- BBIO -0.24
- Stochastic Oscillator
- SSD 85.77
- BBIO 10.35
About SSD Simpson Manufacturing Company Inc.
Simpson Manufacturing Co Inc is a manufacturer of wood construction products. The company offers connectors, truss plates, fastening systems, fasteners, prefabricated lateral systems, concrete construction products, adhesives, mechanical anchors, carbide drill bits, powder-actuated tools, and fiber-reinforced materials. Simpson Manufacturing markets its products to the residential, light industrial, and commercial construction markets as well as the remodeling and do-it-yourself markets. The Company is organized into three reporting segments defined by the regions namely North America, Europe, and Asia Pacific. The company generates the majority of its revenue from wood products.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.